1 Просмотры
Издатель
Stakeholders from policy and science talked about historical, present and future developments of the BIH Charité Clinician Scientist Program in Berlin. The science policy session was chaired by Ulrich Dirnagl, Director of the QUEST Center for Responsible Research, Berlin Institute of Health at Charité (BIH), Germany and Martin E. Kreis, Chief Medical Officer, Charité – Universitätsmedizin Berlin, Germany.

00:02:49 Heyo K. Kroemer, Chief Executive Officer of the Charité – Universitätsmedizin Berlin, Germany, “Significance of the BIH Charité Clinician Scientist Program with a view to the Charité Strategy 2030 »Rethinking Health!«”

00:18:55 Peter Bobbert, President of the Berlin Chamber of Physicians, Germany, “The BIH Charité Clinician Scientist Program from the perspective of the Berlin Chamber of Physicians”

00:23:40 Matthias Frosch, President of the German Association of Medical Faculties – MFT, Dean of the Medical Faculty Würzburg, Germany, “The BIH Charité Clinician Scientist Program from the perspective of the German Association of Medical Faculties – MFT”

00:34:48 Martin Reinhart and Barbara Hendriks, German Centre for Higher Education Research and Science Studies (DZHW), Berlin, Germany, “Empirical results of the BIH Charité Clinician Scientist Program Evaluation”

01:06:17 Nico Riedel, QUEST Center for Responsible Research, Berlin Institute of Health at Charité (BIH), Germany, “Bibliometric Report”


01:22:27 Ramona Lange, Institute of Medical Sociology and Rehabilitation Science, Charité – Universitätsmedizin Berlin, Germany, “Structural Implications of Clinician Scientist Programs on the Biomedical Research Landscape in Germany”




Berlin Institute of Health at Charité (BIH):


Charité - Universitätsmedizin Berlin:
Комментариев нет.